TetraLogic Pharmaceuticals Initiates Phase 1 Clinical Trial: "TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety ..."
" The Roving Giraffe News Report " provided through
Ace News Service
Tuesday, 26 January 2010
Food hormone leptlin as link to Alzheimer's
Food hormone leptlin as link to Alzheimer's: "High levels of a hormone that controls appetite are linked to a reduced risk of developing Alzheimer's, research suggests. This hormone called leptin is produced by fat cells and tells the body that it is full and thus reduces appetite. it has for a long time been touted as a potential way to reduce obesity."
" The Roving Giraffe News Report " provided through Ace News Service
" The Roving Giraffe News Report " provided through Ace News Service
Subscribe to:
Posts (Atom)